BioCentury | Apr 17, 2021
Deals

April 16 Quick Takes: AZ’s $39B Alexion deal clears FTC hurdle; plus Biosplice, C2i, Relay, Surrozen and more

...$24M San Diego-based Molecular Assemblies Inc. raised $24 million in a series A round led by Agilent Technologies...
BioCentury | Mar 17, 2021
Management Tracks

High-profile departures at Sage, bluebird as Cloonan, Davidson depart; plus CBC Group, Turning Point, Agilent, Intercept, Centessa, Beam and more

...previously served as VP of finance at Cleave Biosciences Inc.Katharine Knobil will join diagnostics company Agilent Technologies...
...general counsel. Howton was EVP of legal and general counsel at Sarepta Therapeutics Inc. (NASDAQ:SRPT). Gunjan Ohri Agilent Technologies...
BioCentury | Feb 23, 2021
Product Development

Feb. 22 Quick Takes: Sanofi, J&J in COVID vaccine manufacturing deal; plus AZ, Regeneron-Sanofi, Incyte, Ascletis, Novo-Altasciences, Regor

...whose tumors have high PD-L1 expression confirmed by companion diagnostic PD-L1 IHC 22C3 pharmDx from Agilent Technologies...
BioCentury | Feb 5, 2021
Management Tracks

Chugai names Okuda CEO; plus Astellas promotes Barretto-Ko to CBO, Goto to CSO and updates from Merck KGaA, Scholar Rock, Berkeley Lights, Catamaran and more

...in January as chief human resources officer. Healy was head of next-generation sequencing systems at Agilent Technologies...
BioCentury | Oct 2, 2020
Finance

Sophia aims to parlay expertise of new backers aMoon, Hitachi to grow biopharma business

...Sophia said Didier Hirsch, former CFO at Agilent Technologies...
BioCentury | Aug 13, 2020
Finance

Cell analysis company Mission Bio aiming to scale with $70M series C

Two years after generating its first revenues, single-cell analysis and profiling company Mission Bio hopes to use its new $70 million series C round to scale its commercial operations broadly to help...
BioCentury | Oct 4, 2019
Financial News

Oct. 4 Financial Quick Takes: Innovent raises $300M in Hong Kong's first biotech follow-on; plus Oyster Point, Heron, Molecular Assemblies and Geneoscopy

...million in a series A round led by iSelect Fund, with participation from existing investors, Agilent Technologies...
BioCentury | Oct 3, 2019
Company News

Oct. 2 Company Quick Takes: Merck, Immunovant, PureTech-Ariya, Viscient-Organovo and Durect

...whose tumors express PD-L1. NMPA also approved companion diagnostic PD-L1 IHC 22C3 pharmDx assay from Agilent Technologies...
BioCentury | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

...announce series A funding this fall, adding to a 2016 $2.3 million seed round from Agilent Technologies...
...Klimpel, SGI-DNA’s senior director of global product management and clinical solutions. Companies and Institutions Mentioned Agilent Technologies...
BioCentury | Dec 14, 2018
Finance

Mission: Mainstream

...B round to expand the applications and client base for its single-cell DNA analysis platform. Agilent Technologies...
Items per page:
1 - 10 of 243
BioCentury | Apr 17, 2021
Deals

April 16 Quick Takes: AZ’s $39B Alexion deal clears FTC hurdle; plus Biosplice, C2i, Relay, Surrozen and more

...$24M San Diego-based Molecular Assemblies Inc. raised $24 million in a series A round led by Agilent Technologies...
BioCentury | Mar 17, 2021
Management Tracks

High-profile departures at Sage, bluebird as Cloonan, Davidson depart; plus CBC Group, Turning Point, Agilent, Intercept, Centessa, Beam and more

...previously served as VP of finance at Cleave Biosciences Inc.Katharine Knobil will join diagnostics company Agilent Technologies...
...general counsel. Howton was EVP of legal and general counsel at Sarepta Therapeutics Inc. (NASDAQ:SRPT). Gunjan Ohri Agilent Technologies...
BioCentury | Feb 23, 2021
Product Development

Feb. 22 Quick Takes: Sanofi, J&J in COVID vaccine manufacturing deal; plus AZ, Regeneron-Sanofi, Incyte, Ascletis, Novo-Altasciences, Regor

...whose tumors have high PD-L1 expression confirmed by companion diagnostic PD-L1 IHC 22C3 pharmDx from Agilent Technologies...
BioCentury | Feb 5, 2021
Management Tracks

Chugai names Okuda CEO; plus Astellas promotes Barretto-Ko to CBO, Goto to CSO and updates from Merck KGaA, Scholar Rock, Berkeley Lights, Catamaran and more

...in January as chief human resources officer. Healy was head of next-generation sequencing systems at Agilent Technologies...
BioCentury | Oct 2, 2020
Finance

Sophia aims to parlay expertise of new backers aMoon, Hitachi to grow biopharma business

...Sophia said Didier Hirsch, former CFO at Agilent Technologies...
BioCentury | Aug 13, 2020
Finance

Cell analysis company Mission Bio aiming to scale with $70M series C

Two years after generating its first revenues, single-cell analysis and profiling company Mission Bio hopes to use its new $70 million series C round to scale its commercial operations broadly to help...
BioCentury | Oct 4, 2019
Financial News

Oct. 4 Financial Quick Takes: Innovent raises $300M in Hong Kong's first biotech follow-on; plus Oyster Point, Heron, Molecular Assemblies and Geneoscopy

...million in a series A round led by iSelect Fund, with participation from existing investors, Agilent Technologies...
BioCentury | Oct 3, 2019
Company News

Oct. 2 Company Quick Takes: Merck, Immunovant, PureTech-Ariya, Viscient-Organovo and Durect

...whose tumors express PD-L1. NMPA also approved companion diagnostic PD-L1 IHC 22C3 pharmDx assay from Agilent Technologies...
BioCentury | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

...announce series A funding this fall, adding to a 2016 $2.3 million seed round from Agilent Technologies...
...Klimpel, SGI-DNA’s senior director of global product management and clinical solutions. Companies and Institutions Mentioned Agilent Technologies...
BioCentury | Dec 14, 2018
Finance

Mission: Mainstream

...B round to expand the applications and client base for its single-cell DNA analysis platform. Agilent Technologies...
Items per page:
1 - 10 of 243